Aggressive immunotherapy combined with bortezomib and rituximab for membranous nephropathy associated with enzyme replacement therapy in Pompe disease-Reference-Cited by-同舟云学术

Aggressive immunotherapy combined with bortezomib and rituximab for membranous nephropathy associated with enzyme replacement therapy in Pompe disease

Published:2022-07-21 Issue:3 Volume:38 Page:921-925
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Sasaki Keigo,Uchimura Toru,Inaba Aya,Otani Masako,Hanakawa Junko,Ito Shuichi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s00467-022-05672-5.pdf

Reference15 articles.

1. Kishnani PS, Steiner RD, Bali D, Berger K et al (2006) Pompe disease diagnosis and management guideline. Genet Med 8:267–288. https://doi.org/10.1097/01.gim.0000218152.87434.f3

2. Kishnani PS, Corzo D, Nicolino M, Byrne B et al (2007) Recombinant human acid α-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 68:99–109. https://doi.org/10.1212/01.wnl.0000251268.41188.04

3. Chien YH, Lee NC, Thurberg BL, Chiang SC et al (2009) Pompe disease in infants: improving the prognosis by newborn screening and early treatment. Pediatrics 124:e1116–e1125. https://doi.org/10.1542/peds.2008-3667

4. Toscano A, Schoser B (2013) Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260:951–959. https://doi.org/10.1007/s00415-012-6636-x

5. Hanna D, Vassili V, Olivia B, Laure-Helene N et al (2014) Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy. J Am Soc Nephrol 25:675–680. https://doi.org/10.1681/ASN.2013030290

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing treatment outcomes: immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy;Frontiers in Immunology;2024-04-23

2. Alglucosidase-alfa;Reactions Weekly;2023-03-18